The category of StARD5 Activators encompasses a diverse array of chemical entities that, while not directly interacting with StARD5, play crucial roles in the activation or regulation of signaling pathways and cellular processes that can influence the activity of the StARD5 protein. These compounds range from lipid molecules like cholesterol, vital for the intrinsic functionality of StARD5 in lipid transfer, to various activators or agonists for peroxisome proliferator-activated receptors (PPARs), such as rosiglitazone, pioglitazone, and WY-14643. These PPAR activators are pivotal as they govern lipid and glucose metabolism, thus potentially crossing paths with StARD5-related activities in lipid transfer and cellular homeostasis.
Moreover, the list includes compounds like forskolin and 8-Bromo-cAMP that work upstream in the signaling cascade by modulating cAMP levels, a key secondary messenger in numerous biological processes, including lipid metabolism in which StARD5 is implicated. The presence of retinoic acid and dexamethasone highlights the influence of substances that can alter gene expression and subsequently impact metabolic pathways relevant to StARD5's function. These chemicals collectively underline the intricate network of intracellular signaling mechanisms and metabolic pathways that, when modulated, have the capacity to influence StARD5 activity indirectly, underscoring the protein's integrated role in cellular metabolism.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing intracellular cAMP levels, thereby potentially promoting StARD5-mediated processes through signaling cascades. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that permeates cells and activates cAMP-dependent pathways, possibly affecting StARD5 activity through secondary messengers. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $27.00 $2809.00 $129.00 $210.00 $583.00 $88.00 | 11 | |
As StARD5 is implicated in lipid transfer, the presence of substrates like cholesterol can modulate its activity. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
A PPARγ agonist, influencing lipid and glucose metabolism, potentially intersecting with StARD5-related pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
By modulating gene expression, it influences cellular differentiation and may impact lipid transfer processes involving StARD5. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Activates PPARγ, potentially affecting lipid homeostasis and processes where StARD5 is relevant. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid that influences various metabolic processes and may intersect with lipid transfer roles of StARD5. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $136.00 | 7 | |
A synthetic PPARα agonist that can influence lipid metabolism pathways, potentially affecting StARD5 activity. | ||||||
GW 0742 | 317318-84-6 | sc-203991 sc-203991A | 10 mg 50 mg | $194.00 $831.00 | 11 | |
A PPARδ agonist that, by altering lipid profiles, can intersect with the functional pathways of StARD5. | ||||||